Literature DB >> 21934126

Muscle strength and sedative load in community-dwelling people aged 75 years and older: a population-based study.

Heidi T Taipale1, J Simon Bell, Danijela Gnjidic, Raimo Sulkava, Sirpa Hartikainen.   

Abstract

BACKGROUND: Use of psychotropic and sedative drugs has been associated with impaired muscle strength. Muscle weakness predicts important outcomes for older people including functional disability and mortality. The objective of this study was to investigate if the use of drugs with sedative properties is associated with poorer muscle strength.
METHODS: Seven-hundred community-dwelling participants, aged 75 years and older, enrolled in the population-based Geriatric Multidisciplinary Strategy for the Good Care of the Elderly (GeMS) study in 2004 were included in the present analyses. Data on demographics, diagnostics, and drug use were collected during standardized interviews, conducted by trained nurses and verified through medical records. Physiotherapists conducted objective tests of handgrip strength, knee extension strength, and the five repeated chair stands test. Sedative load was calculated using a previously published model for each participant.
RESULTS: Twenty-one percent of the participants (n = 147) had a sedative load of 1-2 and 8% (n = 58) had a sedative load 3 or more. After adjusting for covariates, participants with sedative load more than 0 had poorer performance on grip strength (p = .009), knee extension strength (p = .02), and five chair stands (p = .003) than nonusers of drugs with sedative properties. Increasing sedative load was associated with poorer grip strength.
CONCLUSIONS: Use of drugs with sedative properties was associated with impaired muscle strength. Although we adjusted for diagnoses affecting physical function, the possibility of confounding by indication cannot be entirely excluded. Given that muscle strength is predictive of functional disability and mortality, further attention should be directed toward conducting regular reviews of drug therapy and reducing use of sedative drugs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934126     DOI: 10.1093/gerona/glr170

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  6 in total

1.  Potentially inappropriate drug use among older persons in Finland: application of a new national categorization.

Authors:  J Simon Bell; Jouni Ahonen; Piia Lavikainen; Sirpa Hartikainen
Journal:  Eur J Clin Pharmacol       Date:  2012-08-14       Impact factor: 2.953

2.  Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons.

Authors:  Heidi Taipale; Antti Tanskanen; Marjaana Koponen; Anna-Maija Tolppanen; Jari Tiihonen; Sirpa Hartikainen
Journal:  Clin Epidemiol       Date:  2016-10-11       Impact factor: 4.790

3.  Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models.

Authors:  Sweilem B Al Rihani; Malavika Deodhar; Lucy I Darakjian; Pamela Dow; Matt K Smith; Ravil Bikmetov; Jacques Turgeon; Veronique Michaud
Journal:  Drugs Aging       Date:  2021-11-09       Impact factor: 3.923

4.  Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.

Authors:  Heidi Taipale; Marjaana Koponen; Antti Tanskanen; Piia Lavikainen; Reijo Sund; Jari Tiihonen; Sirpa Hartikainen; Anna-Maija Tolppanen
Journal:  Alzheimers Res Ther       Date:  2017-08-01       Impact factor: 6.982

5.  Prevalence of probable sarcopenia in community-dwelling older Swiss people - a cross-sectional study.

Authors:  Julia Wearing; Peter Konings; Rob A de Bie; Maria Stokes; Eling D de Bruin
Journal:  BMC Geriatr       Date:  2020-08-26       Impact factor: 3.921

6.  Gross motor developmental dysfunctional outcomes in infantile and toddler pediatric intensive care unit survivors.

Authors:  Chun-Feng Yang; Yang Xue; Jun-Yan Feng; Fei-Yong Jia; Yu Zhang; Yu-Mei Li
Journal:  BMC Pediatr       Date:  2019-12-21       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.